Get the Stockscreener App
1.56
1.30%
0.02
Opko Health Inc stock is traded at $1.56, with a volume of 1.71M.
It is up +1.30% in the last 24 hours and up +13.04% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
See More
Previous Close:
$1.54
Open:
$1.54
24h Volume:
1.71M
Relative Volume:
0.70
Market Cap:
$1.24B
Revenue:
$711.41M
Net Income/Loss:
$-133.73M
P/E Ratio:
-8.2105
EPS:
-0.19
Net Cash Flow:
$-199.99M
1W Performance:
+7.59%
1M Performance:
+13.04%
6M Performance:
-0.64%
1Y Performance:
+3.31%
1-Day Range:
$1.54
$1.59
1-Week Range:
$1.44
$1.59
52-Week Range:
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.56 | 1.22B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-25-25 | Initiated | JP Morgan | Neutral |
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
What institutional flow reveals about OPKO Health Inc.Market Risk Analysis & Free Real-Time Market Sentiment Alerts - newser.com
Technical signs of recovery in OPKO Health Inc.July 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
How OPKO Health Inc. (XCY) stock reacts to stronger dollar2025 Growth vs Value & Long-Term Growth Stock Strategies - newser.com
Can machine learning forecast OPKO Health Inc. recoveryEntry Point & Smart Investment Allocation Insights - newser.com
Why OPKO Health Inc. stock attracts global investorsRate Hike & Safe Entry Point Alerts - newser.com
How OPKO Health Inc. stock performs in weak economyTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Ranking OPKO Health Inc. among high performing stocks via toolsTrade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com
Opko Health (OPK) Reports Fiscal Q2 2025 Results - MSN
What machine learning models say about OPKO Health Inc.July 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance
What analysts say about OPKO Health Inc stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
12 Healthcare Stocks with Insider Buying in 2025 - Insider Monkey
How to manage a losing position in OPKO Health Inc.Recession Risk & Weekly High Return Forecasts - newser.com
Down Syndrome Market: Epidemiology, Therapies, Companies, DelveInsight | AC Immune, Annovis Bio, Alzheon, OPKO Health, Inc., Aelis Farma - Barchart.com
44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance
Opko Health, Inc. (OPK) Stock Analysis: Unlocking a Potential 151% Upside with Strategic Healthcare Innovations - DirectorsTalk Interviews
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Voya Investment Management LLC Lowers Position in OPKO Health, Inc. $OPK - MarketBeat
Veracyte (NASDAQ:VCYT) vs. OPKO Health (NASDAQ:OPK) Financial Analysis - Defense World
Pullback Watch: Whats the beta of OPKO Health Inc stock2025 Macro Impact & Free Real-Time Market Sentiment Alerts - khodrobank.com
New Highs: What is the dividend yield of OPKO Health IncTrade Performance Summary & Long-Term Safe Investment Plans - khodrobank.com
OPKO Health Hits Day High with Strong 8.63% Intraday Surge - Markets Mojo
Analyst Downgrade: Is ARMK benefiting from innovation trendsJuly 2025 Intraday Action & Stepwise Swing Trade Plans - khodrobank.com
Targets Report: Will OPKO Health Inc outperform its industry peersTrade Risk Assessment & Community Verified Trade Alerts - خودرو بانک
OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up - simplywall.st
Analyst Upgrade: What is the long term forecast for OPKO Health Inc stockQuarterly Profit Summary & Expert Curated Trade Setups - خودرو بانک
OPKO Health Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
What is the Moat Score of OPKO Health IncJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - خودرو بانک
LH Stock Rises on Acquisition of BioReference Health's Select Assets - sharewise.com
Lab giant acquires $225 million cancer testing assets tied to health company led by Miami billionaire Phillip Frost - The Business Journals
Levels Update: Is Douglas Emmett Inc. exposed to currency risks2025 Support & Resistance & Reliable Momentum Entry Alerts - خودرو بانک
Risk Off: What is the long term forecast for OPKO Health Inc stockForecast Cut & Precise Swing Trade Entry Alerts - خودرو بانک
Is OPKO Health Inc forming bullish engulfing patterns2025 EndofYear Setup & Daily Technical Stock Forecast Reports - خودرو بانک
Aug Catalysts: Is OPKO Health Inc. affected by consumer sentiment2025 Stock Rankings & Safe Investment Capital Preservation Plans - khodrobank.com
Whale Trades: Is OPKO Health Inc likely to announce a buybackWeekly Market Report & Weekly Chart Analysis and Guides - خودرو بانک
Labcorp completes $225M acquisition of BioReference Health's diagnostics business assets - The Business Journals
Forecast Cut: What is OPKO Health Inc. s 5 year growth outlookBuy Signal & High Accuracy Trade Signal Alerts - خودرو بانک
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.01%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):